Skip to main content

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Projects

CIBER: Enfermedades respiratorias

IP: CIBER: Enfermedades respiratorias
Collaborators: Carles Bravo Masgoret, Mª Jesús Cruz Carmona
Funding agency: CIBER en Enfermedades Respiratorias
Funding:
Reference: CB06/06/0030
Duration: 01/01/2007 - 31/12/2010

Asma ocupacional en profesionales de peluquería: prevalencia, agentes causales y determinantes ambientales

IP: Mª Jesús Cruz Carmona
Collaborators: -
Funding agency: SOCIETAT CATALANA DE PNEUMOLOGIA
Funding: 18000
Reference: SOCAP/01/2005
Duration: 01/01/2005 - 01/01/2007

Asma ocupacional en profesionales de peluquería: prevalencia, agentes causales y determinantes ambientales

IP: Fco. Javier Muñoz Gall
Collaborators: Asma ocupacional en profesionales de peluquería: prevalencia, agentes causales y determinantes ambientales, Maria Antonia Ramon Belmonte, Mª Jesús Cruz Carmona, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 53550
Reference: PI050100
Duration: 01/01/2006 - 31/12/2008

Investigación cooperativa en enfermedades respiratorias

IP: Investigación cooperativa en enfermedades respiratorias
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Investigación cooperativa en enfermedades respiratorias, Investigación cooperativa en enfermedades respiratorias, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 43435
Reference: PI051344
Duration: 01/01/2006 - 31/12/2006

Related news

Dr. Miravitlles’ career was recognized during the 57th edition of the SEPAR National Congress held in Valencia.

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Patricia Muñoz Cabello

Patricia Muñoz Cabello

Read more
Gloria Fatou Royo Gomes

Gloria Fatou Royo Gomes

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Albert Monserrat Companys

Albert Monserrat Companys

Read more
Mª Engracia Perez Mezquina

Mª Engracia Perez Mezquina

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.